Concepedia

Andrew McGarry

AM

Statistics

Publications

18

Citations

1.1K

H-Index

15

Active since

2016

Affiliations

Cooper University Hospital(Current)

University of Rochester

Cooper Medical School of Rowan University

Teva Pharmaceuticals (United States)

University of Rochester Medical Center

Andrew McGarry is an author at Cooper University Hospital specializing in neurodegenerative diseases, medicine, and neurodegenerative disorders.

ORCID

Publications per year

2016–2025

18

Publications

18

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

Samuel Frank, Claudia Testa, David Stamler et al. · JAMA · 2016 · 398 citations · Full text

, , +16

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry, Michael McDermott, Karl Kieburtz et al. · Neurology · 2016 · 137 citations · Full text

, , +16

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Andrew McGarry, Shane Rosanbalm, Mika Leinonen et al. · The Lancet Neurology · 2023 · 129 citations

, , +9

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 108 citations

, , +10

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial

Samuel Frank, Claudia Testa, David Stamler et al. · Publisher · 2016 · 44 citations

, , +10

1–5 of 18